FIELD: organic chemistry, medicine, chemical-pharmaceutical industry, pharmacy.
SUBSTANCE: invention relates to a new agent with expressed selective activity with respect to central muscarinic acetylcholine receptors belonging to subtype M1. Agent represents 1-phenyl-1-(1'-methylcyclopentyl)-4-piperidino-2-butyne-1-ol hydrochloride of the formula (1) 
known early as low toxic cholinolytic. Agent expands a set of ligands used in research of mechanisms of the central nervous system function. Agent shows high capacity for penetration through blood-brain barrier, low toxicity and high effectiveness.
EFFECT: valuable medicinal properties of agent.
1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| 1-PHENYL-1-CYCLOPENTYL-4-PIPERIDINO-2-BUTYNE-1-OL HYDROCHLORIDE (PENTIFIN) ELICITING M4 CHOLINE-BLOCKING ACTIVITY | 2002 |
|
RU2224516C1 |
| 1-PHENYL-1-CYCLOPENTYL-4-PIPERIDINO-2 BUTIN-1-OLA HYDROCHLORIDE POSSESSING ACTIVITY IN TREATING AND PREVENTING PARKINSONISM | 1998 |
|
RU2184542C2 |
| ANTICHOLINERGIC AGENT | 1987 |
|
RU2014074C1 |
| APPLICATION OF 10-[(3R)-1-AZABICYCLO[2,2,2]OCT-3-YLMETHTYL]-10H-PHENOTHIAZINE FOR PREPARING DRUG SELECTIVELY INHIBITING MUSCARINE RECEPTORS M1L, M2 AND M3 | 2007 |
|
RU2449794C2 |
| (1-METHYLPIPERIDIN-4-YL)-2-PROPYL PENTANOATE HYDROCHLORIDE, HAVING CHOLINOLYTIC AND ANTICONVULSANT ACTIVITY | 2019 |
|
RU2714135C1 |
| TREATING PSYCHOLOGICAL CONDITIONS WITH USING M-MUSCARINIC ANTAGONISTS | 2007 |
|
RU2477634C2 |
| AMINOALCOHOLS OF ACETYLENE ORDER SHOWING EXPRESSED M-CHOLINO-LYTIC PROPERTY AND WEAKLY SUPPRESSING CENTRAL NERVOUS SYSTEM | 1998 |
|
RU2155759C2 |
| TREATMENT OF OBESITY WITH ANTAGONISTS OF MUSCARINIC RECEPTOR M1 | 2007 |
|
RU2455981C2 |
| TREATMENT OF OVERACTIVE BLADDER SYNDROME | 2022 |
|
RU2792534C1 |
| STEROID SAPOGENINS AND THEIR DERIVATIVES USABLE IN MEDICAL TREATMENT | 2004 |
|
RU2297228C2 |
